Related Experiment Video
Updated: Aug 14, 2026

A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells
Published on: July 31, 2012
Effect of peptide Lys-Glu on interleukin-2 gene expression in lymphocytes
V K Khavinson1, V G Morozov, V V Malinin
1Institute of Biological Regulation and Gerontology, Northwestern Division of the Russian Academy of Medical Sciences, St. Petersburg. vvm@medport.ru
Insights
Lysine-Glutamine (Lys-Glu) peptide stimulates interleukin-2 gene expression in mouse lymphocytes. This suggests Lys-Glu may be a key regulatory fragment for gene transcription and nuclear factor transport.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Interleukin-2 (IL-2) is a critical cytokine for immune responses.
- Regulation of IL-2 gene expression involves complex transcription factor interactions.
- Identifying regulatory elements is crucial for understanding immune cell activation.
Purpose of the Study:
- To investigate the effect of Lys-Glu peptide on IL-2 gene expression in mouse lymphocytes.
- To determine the dose and time dependency of Lys-Glu's effect.
- To explore the potential role of Lys-Glu in nuclear transport and gene transcription.
Main Methods:
- In vitro stimulation of mouse spleen lymphocytes.
- Treatment with Lys-Glu peptide at varying concentrations and durations.
- Assessment of interleukin-2 gene expression.
Main Results:
- Lys-Glu peptide significantly stimulated IL-2 gene expression in a dose- and time-dependent manner.
- The peptide's effect suggests a role in regulating transcription.
- Potential involvement in the transport of trans-acting factors to the nucleus was observed.
Conclusions:
- Lys-Glu peptide acts as a potent stimulator of IL-2 gene expression in lymphocytes.
- This peptide may represent the shortest regulatory fragment involved in IL-2 gene activation.
- Lys-Glu could be a structural component of active centers for trans-acting factors in IL-2 gene transcription.
Abstract:
Lys-Glu in vitro stimulated interleukin-2 gene expression in mouse spleen lymphocytes. This effect depended on peptide concentration and duration of treatment. It is hypothesized that this peptide is the shortest regulatory fragment promoting the transport of trans-acting factors into the nucleus. It can not be excluded that Lys-Glu is a structural component of trans-acting factor active centers, which are necessary for the activation of interleukin-2 gene transcription in lymphocytes.

